“…Moreover, there is no account correlating WS·IPA solubility and solvent composition, which are fundamental parameters needed to engineer an antisolvent cooling crystallization process for this or other compounds . The selection of the crystallization solvent also affects nucleation and growth kinetics, crystal morphology, and structure − that in turn influence the physicochemical properties of the active pharmaceutical ingredient and its performance. , Hence, the present study focuses on the determination of the solubility of WS·IPA in four pure solvents (acetone, ethanol, IPA, and water), five binary mixtures (IPA + acetone, IPA + ethanol, IPA + water, IPA + heptane, and IPA + hexane), and five ternary mixtures (IPA + acetone + heptane, IPA + acetone + hexane, IPA + ethanol + heptane, IPA + ethanol + hexane, and IPA + water + heptane) at temperatures ranging from 278.15 to 333.15 K using the polythermal method in a Crystal16 multiple reactor system. ,,,− The solvents are categorized as class 3 by the Food and Drug Administration (less toxic and lower risks to human health) except hexane, which is a class 2 solvent . However, hexane is commonly used as an antisolvent in pharmaceutical crystallization processes. ,, The experimental solubility data were correlated employing the modified Apelblat and λh model equations, which enable the interpolation and extrapolation of the determined solubility, providing a better understanding of the solubility profile for WS·IPA.…”